Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.

CONCLUSION: There was no difference between VTE recurrence and choice of anticoagulation in SCD patients with VTE. Bleeding events were lower for DOACs compared to VKA or LMWH. PMID: 31108496 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31108496?dopt=Abstract

Source: Acta Haematologica - May 19, 2019 Category: Hematology Authors: Patel A, Williams H, Baer MR, Zimrin AB, Law JY Tags: Acta Haematol Source Type: research